GO:1900107 regulation of nodal signaling pathway: Embryonic Patterning, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900107 (regulation of nodal signaling pathway) is a biological process that modulates the frequency, rate or extent of Nodal signaling, a TGF-beta superfamily pathway essential for germ layer formation and mesendoderm induction.
• Nodal signaling is controlled at multiple levels, including receptor interactions, positive feedback loops, receptor trafficking, and metabolic inputs such as glycolytic activity.
• Key regulators include Nodal ligands, the co-receptor EGF-CFC (e.g., Cripto), type I/II receptors (ACVR1B, ACVR2A/B), and intracellular Smad2/3 effectors.
• Dysregulation of Nodal signaling is linked to placental pathologies, preeclampsia, and developmental defects, making it a target for disease modeling.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of Nodal pathway regulation in stem cells and organoids.
• Understanding GO:1900107 provides mechanistic insights into TGF-beta cross-talk and cell-fate decisions, with applications in regenerative medicine and cancer research.
Description
The regulation of nodal signaling pathway (GO:1900107) encompasses any process that modulates the frequency, rate or extent of Nodal signaling, a conserved TGF-beta superfamily pathway critical for embryonic development. Nodal signaling governs mesendoderm formation, left-right asymmetry, and germ layer specification, and its precise regulation is essential for normal embryogenesis. Dysregulation of this pathway has been implicated in placental disorders, diabetic complications, and cancer, underscoring its biomedical importance. Researchers study GO:1900107 to understand how extracellular cues, receptor dynamics, and intracellular feedback loops converge to shape cell-fate decisions. This article synthesizes current knowledge from authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the pathway's regulation, key genes, and experimental models.
regulation of nodal signaling pathway At A Glance
| GO ID | GO:1900107 |
|---|---|
| GO term | regulation of nodal signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of nodal signaling; regulation of nodal signalling pathway |
| Major function | Modulates the frequency, rate or extent of Nodal signaling, influencing mesendoderm induction and germ layer patterning |
| Key regulators | Nodal ligands, EGF-CFC co-receptors, ACVR1B/ACVR2A/B receptors, Smad2/3, and feedback inhibitors |
| Associated processes | Mesendoderm formation, left-right asymmetry, placental development, and TGF-beta cross-talk |
| Disease relevance | Preeclampsia, diabetic placental dysfunction, and developmental anomalies |
What Is GO:1900107?
GO:1900107 is defined as any process that modulates the frequency, rate or extent of nodal signaling pathway. In practice, this includes mechanisms that enhance or suppress Nodal signal transduction, such as changes in ligand availability, receptor complex assembly, co-receptor interactions, Smad activation, and feedback regulation.
Why Is regulation of nodal signaling pathway Important in Cell Biology?
Regulation of Nodal signaling is fundamental to embryonic development and tissue homeostasis, as it controls the balance between pluripotency and differentiation. Aberrant regulation contributes to placental pathologies such as preeclampsia and diabetic embryopathy, and influences cancer progression through TGF-beta cross-talk. Understanding GO:1900107 thus has broad implications for developmental biology, reproductive medicine, and oncology.
• Controls mesendoderm and definitive endoderm formation during gastrulation.
• Regulates left-right axis specification and organ laterality.
• Modulates germ layer proportions in response to metabolic cues such as glycolysis.
• Involved in placental development and function, with links to preeclampsia.
• Cross-talks with other signaling pathways (e.g., Wnt, FGF) to coordinate cell fate.
• Dysregulation is associated with diabetic placental insufficiency.
• Provides a paradigm for understanding TGF-beta superfamily regulation.
• Target for stem cell differentiation protocols and regenerative medicine.
• Offers insights into cancer stem cell maintenance and metastasis.
• Enables precise disease modeling via CRISPR-based genome editing.
What Happens During regulation of nodal signaling pathway?
Ligand Availability and Receptor Interactions
In simple terms: Nodal protein binds to receptors on the cell surface, but this process is tightly controlled by other proteins that help or hinder the interaction.
Nodal ligands are secreted TGF-beta family proteins that form complexes with EGF-CFC co-receptors (e.g., Cripto) to engage type I and type II serine/threonine kinase receptors. Regulation occurs at the level of ligand processing, diffusion, and receptor binding. Preiß et al. (2022) demonstrated that receptor interactions and positive feedback loops regulate Nodal signaling propagation, ensuring robust yet adaptable signaling. Additionally, Rap2-directed receptor trafficking modulates activin/Nodal signaling by controlling the availability of receptors at the cell surface.
Intracellular Signal Transduction via Smads
In simple terms: Once the signal reaches inside the cell, proteins called Smads carry the message to the nucleus to turn genes on or off.
Activated type I receptors phosphorylate Smad2 and Smad3, which then form complexes with Smad4 and translocate to the nucleus to regulate target gene transcription. This canonical pathway is subject to regulation by inhibitory Smads (Smad6/7) and cross-talk with other signaling cascades, such as MAPK and PI3K/AKT, which can modulate Smad activity. Luo (2017) highlighted the extensive cross-talk between TGF-beta/Smad and other pathways, underscoring the complexity of Nodal regulation.
Feedback Regulation and Network Motifs
In simple terms: The pathway can turn itself up or down through feedback loops, like a thermostat controlling temperature.
Nodal signaling is reinforced by positive feedback loops involving Nodal itself and its targets, but it is also restrained by negative feedback via inhibitors such as Lefty and Cerberus. Preiß et al. (2022) showed that positive feedback combined with receptor interactions creates a switch-like response that sharpens signaling boundaries. Wei et al. (2018) reviewed molecular regulation of Nodal signaling during mesendoderm formation, emphasizing the role of feedback inhibitors in shaping spatial and temporal signaling dynamics.
Metabolic and Environmental Inputs
In simple terms: The cell's metabolic state, such as how much sugar it burns, can influence Nodal signaling.
Stapornwongkul et al. (2025) demonstrated that glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling, linking cellular metabolism to developmental signaling. This metabolic regulation adds a layer of control over Nodal pathway activity, integrating nutrient status with cell-fate decisions. Such inputs are critical for understanding how environmental factors influence embryogenesis and stem cell differentiation.
Temporal and Spatial Control in Development
In simple terms: The timing and location of Nodal signals are carefully controlled to build the embryo correctly.
During gastrulation, Nodal signaling is dynamically regulated in space and time to pattern the mesendoderm and establish left-right asymmetry. Rito et al. (2025) showed that timely inhibition of TGF-beta signaling induces notochord formation, highlighting the importance of precise temporal regulation. Choi et al. (2008) further revealed that Rap2-directed receptor trafficking is essential for regulating activin/Nodal signaling during early development.
Key Genes Involved in GO:1900107 regulation of nodal signaling pathway
The following genes and proteins are central to the regulation of Nodal signaling (GO:1900107), as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NODAL | Ligand that activates Nodal signaling | Core pathway component; knockout disrupts mesendoderm formation |
| CRIPTO (TDGF1) | EGF-CFC co-receptor for Nodal | Essential for Nodal signaling; knockout impairs gastrulation |
| ACVR1B (ALK4) | Type I receptor for Nodal | Mediates Smad2/3 phosphorylation; mutations affect signaling |
| ACVR2A/B | Type II receptors for Nodal | Required for ligand binding and receptor activation |
| SMAD2 | Intracellular effector | Transduces Nodal signals to nucleus; knockout blocks mesendoderm |
| SMAD3 | Intracellular effector | Modulates Nodal target genes; cross-talk with other pathways |
| SMAD4 | Common Smad | Forms complexes with Smad2/3; essential for signaling |
| LEFTY1/2 | Feedback inhibitors | Negative regulators of Nodal; restrict signaling range |
| CER1 | Secreted inhibitor | Binds Nodal ligands to inhibit signaling |
| RAP2 | Small GTPase | Regulates receptor trafficking and activin/Nodal signaling |
| EBAF (LEFTY-A) | TGF-beta family member | Involved in placental Nodal signaling regulation |
| p27 (CDKN1B) | Cell cycle inhibitor | Downstream effector in EBAF/Nodal pathway in placenta |
| WNT3A | Wnt ligand | Cross-talks with Nodal to regulate germ layer proportions |
| GLYCOLYSIS GENES (e.g., PFKP) | Metabolic enzymes | Glycolytic activity modulates Nodal signaling |
| FOXH1 | Transcription factor | Mediates Nodal-induced gene expression |
| MIXL1 | Transcription factor | Nodal target involved in mesendoderm differentiation |
| GSC | Transcription factor | Nodal target for organizer formation |
How Is regulation of nodal signaling pathway Regulated?
Regulation of Nodal signaling (GO:1900107) is achieved through multiple mechanisms, including receptor trafficking, feedback loops, and metabolic inputs. Rap2-directed receptor trafficking controls the surface availability of activin/Nodal receptors, thereby modulating signal strength. Positive and negative feedback loops involving Nodal itself, Lefty, and Cerberus fine-tune signaling dynamics. Additionally, glycolytic activity influences Nodal signaling to instruct germ layer proportions, linking metabolism to developmental regulation. Cross-talk with other pathways, such as Wnt and FGF, further integrates Nodal signals into broader cellular networks.
regulation of nodal signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EBAF (LEFTY-A) | Diabetic placental insufficiency | Knockout rat model; placental explants |
| NODAL | Developmental defects (mesendoderm) | CRISPR knockout in hESCs; zebrafish |
| ACVR1B | Cancer (pancreatic, breast) | Point mutation knock-in in cancer cell lines |
| SMAD2 | Left-right asymmetry defects | Knockout mouse; organoids |
| RAP2 | Receptor trafficking defects | Overexpression and knockdown in Xenopus |
Nodal Signaling in Placental Disorders
Dysregulation of Nodal signaling has been implicated in placental pathologies. Gao et al. (2022) demonstrated that the EBAF/Nodal/p27 signaling pathway plays a role in placental development in normal and diabetic rats, suggesting that impaired Nodal regulation contributes to diabetic placental insufficiency. Horvat Mercnik et al. (2024) reviewed TGF-beta signaling as a nexus between inflammation, placental health, and preeclampsia, highlighting Nodal pathway components as potential mediators of disease.
Nodal Signaling and Cancer
Nodal signaling is reactivated in various cancers and promotes tumor progression, stemness, and metastasis. Cross-talk between TGF-beta/Smad and other oncogenic pathways amplifies Nodal effects, making it a target for cancer therapy. However, direct evidence linking GO:1900107 regulation to specific cancers requires further study, and current understanding is largely based on TGF-beta superfamily mechanisms.
Developmental Defects and Left-Right Asymmetry
Disruption of Nodal signaling regulation leads to severe developmental defects, including abnormal left-right patterning and mesendoderm deficiencies. Rito et al. (2025) showed that timely inhibition of TGF-beta signaling is required for notochord induction, and its perturbation causes axial defects. These findings underscore the importance of precise regulation for normal embryogenesis.
From regulation of nodal signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate Nodal signaling in stem cells? | CRISPR knockout in hESCs followed by mesendoderm differentiation |
| How do point mutations in ACVR1B affect Nodal signaling? | Point mutation knock-in in HEK293T or cancer cell lines |
| What is the effect of Nodal overexpression on germ layer proportions? | Doxycycline-inducible overexpression in hESCs |
| Where is Nodal receptor localized during signaling? | Tagged knock-in (e.g., GFP-ACVR1B) and live imaging |
| How does glycolytic flux modulate Nodal signaling? | Metabolic perturbation in hESCs with CRISPR knockout of glycolytic genes |
| What is the role of feedback inhibitors in patterning? | Knockout of LEFTY1/2 in zebrafish or mouse embryos |
How to Study the regulation of nodal signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify Nodal target genes and feedback regulators |
| Phosphoproteomics | Phosphorylation of Smad2/3 and other proteins | Quantify pathway activation |
| Live-cell imaging | Subcellular localization and dynamics of receptors | Study receptor trafficking |
| CRISPR knockout screening | Gene essentiality for Nodal signaling | Discover novel regulators |
| ChIP-seq | Smad2/3 binding sites on DNA | Map direct target genes |
| Reporter assays | Transcriptional activity of Nodal targets | Measure signaling strength |
| Metabolic flux analysis | Glycolytic rate | Link metabolism to Nodal signaling |
Transcriptomic Analysis (RNA-seq)
RNA sequencing measures global gene expression changes upon perturbation of Nodal signaling regulators. It is used to identify downstream targets and feedback components, as demonstrated in studies of mesendoderm differentiation.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry-based proteomics quantifies protein abundance and phosphorylation status of Smad2/3 and other pathway components, providing insights into signaling dynamics.
Imaging and Reporter Assays
Live-cell imaging with fluorescently tagged receptors or Nodal-responsive reporters (e.g., Smad-binding element-GFP) visualizes signaling activation and receptor trafficking in real time.
CRISPR Library Screening
Genome-wide CRISPR knockout screens identify novel regulators of Nodal signaling. Cells are treated with pathway modulators and sorted based on reporter activity to enrich for genes affecting signaling.
How CRISPR Can Be Used to Study GO:1900107 regulation of nodal signaling pathway
Knockout
CRISPR knockout of Nodal pathway genes (e.g., NODAL, SMAD2) in hESCs or model organisms ablates signaling, revealing essential functions in mesendoderm formation and left-right asymmetry. Knockout models are also used to study disease mechanisms, such as placental dysfunction.
Point Mutation
Point mutations in receptor genes (e.g., ACVR1B) or Smad proteins can mimic human disease variants or alter signaling specificity. CRISPR-mediated point mutation knock-in enables precise functional interrogation of these residues.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci allows real-time visualization of protein localization and dynamics. Tagged knock-in of Nodal receptors has been used to track receptor trafficking.
Overexpression
CRISPR activation (CRISPRa) or inducible overexpression systems drive Nodal pathway components above physiological levels, enabling gain-of-function studies. Overexpression of Nodal or glycolytic enzymes modulates germ layer proportions.
How EDITGENE Supports regulation of nodal signaling pathway Research
Researchers studying regulation of nodal signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or is merely correlated with signaling changes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of Nodal pathway regulators.
Contact EDITGENE today to design your custom CRISPR model for regulation of nodal signaling pathway research.
Frequently Asked Questions About regulation of nodal signaling pathway
What is GO:1900107?
GO:1900107 is the Gene Ontology term for regulation of nodal signaling pathway, defined as any process that modulates the frequency, rate or extent of Nodal signaling.
What genes are involved in regulation of nodal signaling pathway?
Key genes include NODAL, CRIPTO, ACVR1B, ACVR2A/B, SMAD2/3/4, LEFTY1/2, CER1, and RAP2.
How is Nodal signaling regulated?
It is regulated by receptor interactions, positive and negative feedback loops, receptor trafficking, and metabolic inputs such as glycolysis.
What diseases are associated with Nodal signaling dysregulation?
Dysregulation is linked to placental disorders like preeclampsia, diabetic placental insufficiency, and developmental defects.
What is the role of Nodal signaling in embryonic development?
Nodal signaling controls mesendoderm formation, germ layer patterning, and left-right asymmetry.
How can I study regulation of nodal signaling pathway in the lab?
Use CRISPR knockout, point mutation, knock-in reporters, overexpression, RNA-seq, proteomics, and imaging.
What are the feedback inhibitors of Nodal signaling?
Lefty1/2 and Cerberus are secreted inhibitors that negatively regulate Nodal signaling.
Does glycolysis affect Nodal signaling?
Yes, glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling.
What is the role of Rap2 in Nodal signaling?
Rap2 regulates receptor trafficking, thereby modulating activin/Nodal signaling.
How does TGF-beta cross-talk with Nodal signaling?
TGF-beta/Smad pathways share components with Nodal signaling and exhibit extensive cross-talk with other pathways.
Conclusion
GO:1900107 (regulation of nodal signaling pathway) is a critical biological process that integrates extracellular cues, receptor dynamics, feedback loops, and metabolic inputs to control Nodal signaling. Its precise regulation is essential for embryonic development, and its dysregulation contributes to placental disorders and developmental defects. Advances in CRISPR-based models and multi-omics approaches continue to unravel the complex regulatory networks, offering opportunities for therapeutic intervention and regenerative medicine.
References
- 1. Stapornwongkul KS et al.. 2025. Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling.. Cell Stem Cell 32(5):744-758.e7 PMID: 40245870
- 2. Preiß H et al.. 2022. Regulation of Nodal signaling propagation by receptor interactions and positive feedback.. Elife 11 PMID: 36149406
- 3. Wei S et al.. 2018. Molecular regulation of Nodal signaling during mesendoderm formation.. Acta Biochim Biophys Sin (Shanghai) 50(1):74-81 PMID: 29206913
- 4. Luo K. 2017. Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.. Cold Spring Harb Perspect Biol 9(1) PMID: 27836834
- 5. Gao Q et al.. 2022. Role of EBAF/Nodal/p27 signaling pathway in development of placenta in normal and diabetic rats.. Dev Biol 481:172-178 PMID: 34737126
- 6. Rito T et al.. 2025. Timely TGFβ signalling inhibition induces notochord.. Nature 637(8046):673-682 PMID: 39695233
- 7. Horvat Mercnik M et al.. 2024. TGFβ signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy.. Hum Reprod Update 30(4):442-471 PMID: 38519450
- 8. Choi SC et al.. 2008. Regulation of activin/nodal signaling by Rap2-directed receptor trafficking.. Dev Cell 15(1):49-61 PMID: 18606140
